Sponsor or institution

Clinical trials and research at Alfasigma S.p.A.

As of November 12, 2026, Find a Trial lists 3 clinical trials run by Alfasigma S.p.A. that are recruiting, at sites in 15 countries (most in France (3), Germany (3), United Kingdom (3)). By phase: Phase 3 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Filgotinib for children with polyarticular juvenile idiopathic arthritis Phase 3 Leuven and 13 other locations Recruiting Apr 28, 2026
Open-label extension with filgotinib for juvenile idiopathic arthritis Phase 3 Le Kremlin-Bicêtre and 3 other locations Recruiting Apr 27, 2026
Filgotinib for children and teenagers with ulcerative colitis Phase 3 Brussels, Brussels Capital and 45 other locations Recruiting Mar 7, 2025

All recruiting trials (3)

Quick answers

How many clinical trials run by Alfasigma S.p.A. are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 15 countries. The most sites are in France (3 trials), Germany (3 trials), United Kingdom (3 trials), Belgium (2 trials), Italy (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.